Skip to content

News

Bracketing: what the extremes can and cannot cover

  • News
  • 1 min read

Three strengths in two bottle sizes make six combinations, and bracketing takes only two of them off the stability schedule.

ICH Q1D (2002) defines bracketing as a stability design in which only samples at the extremes of certain design factors, such as strength, container size or fill, are tested at all time points. The design assumes that the stability of the intermediate levels is represented by the extremes.

Apply that to the six. The lowest and the highest strength go on stability in both bottles, which is four combinations. The middle strength in each bottle is the part bracketed out. The bottle size saves nothing here: with two sizes there is no level between them.

The assumption carries conditions. The guideline says the use of any reduced design should be justified. Where different excipients are used among strengths, bracketing generally should not be applied. And if the two extremes behave differently, the intermediates should be considered no more stable than the least stable extreme.

EU GMP Annex 15 (2015 text) uses the same word in its glossary for process validation batches, with strength, batch size and pack size as the factors.

Related

More on this subject

Checks that make a URS line testable

A URS line such as 'the HVAC system shall maintain suitable conditions' cannot be tested. EU GMP Annex 15 (2015) says the URS should be a point of reference throughout the validation life cycle. Five checks make a line usable: one requirement, a unique ID, a number with unit and tolerance, the state, and a named test.

InsightRead

Comparative method transfer: where the criteria come from

In a comparative method transfer, two laboratories test the same lots. EU GMP Chapter 6 says the transfer should be described in a detailed protocol, with acceptance criteria based upon the current validation study of the method. Agree the criteria before execution, train the analysts, compare the results against the criteria and investigate deviations before closure.

InsightRead

CPV: one abbreviation, two different things

Continued process verification is the FDA's Stage 3: assurance during routine production that the process remains in a state of control. EU GMP Annex 15 (2015) calls it ongoing process verification. Continuous process verification, defined in ICH Q8(R2), is an alternative approach to validation. Write the phrase out and cite its source.

InsightRead